Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Oncotarget|December 26, 2015
TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancerHong Yuen Wong, Grace M Wang, Sarah Croessmann, et al.
Clinical Breast Cancer|January 25, 2022
Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair GenesElaine M Walsh, Neha Mangini, John Fetting, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2007
Tamoxifen-stimulated growth of breast cancer due to p21 lossAbde M Abukhdeir, Michele I Vitolo, Pedram Argani, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
Knockin of mutant PIK3CA activates multiple oncogenic pathwaysJohn P Gustin, Bedri Karakas, Michele B Weiss, et al.
Cancer Immunology, Immunotherapy : CII|August 6, 2024
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumorsRavit Geva, Maria Vieito, Jorge Ramon, et al.
Cell|January 30, 2016
Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin CytoskeletonHai Hu, Ashish Juvekar, Costas A Lyssiotis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2023
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid TumorsMaria Vieito, Victor Moreno, Anna Spreafico, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2014
MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancersMorassa Mohseni, Justin Cidado, Sarah Croessmann, et al.
Leukemia Research|September 30, 2023
Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromesTamanna Haque, Felix López Cadenas, Blanca Xicoy, et al.
JCO Precision Oncology|July 14, 2018
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor BoardW Brian Dalton, Patrick M Forde, Hyunseok Kang, et al.
Pageof 5